InvestorsHub Logo
Followers 21
Posts 2540
Boards Moderated 0
Alias Born 12/07/2013

Re: RobinF post# 382928

Tuesday, 07/12/2022 11:04:26 AM

Tuesday, July 12, 2022 11:04:26 AM

Post# of 426225
One could ask why AMRN never included a statin intolerant arm in the original REDUCE IT study? Just another grave oversight - Can EPA compete directly with statins?

EPA gave 25% reduction on top of statins what would have been the risk reduction before statins took the lions share ?

We already know its a statin enhancer but instead we market it as fish oil - the absolute zenith of business buffoonery

When it comes to AMRN bet on buffoonery but I'm not certain it can go much lower, there is a certain amount of value in Canada Europe CHina etc - but knowing the buffoons they may be able to screw that up as well.

NOnetheless I am hesitant to short this stock any longer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News